geoopen

A third generation therapeutic vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: first-in-human trial of ChAd63-KH

GEO Series GSE98212. Homo sapiens. 50 samples. Type: Expression profiling by high throughput sequencing.

ShareScore

24/100

Overall dataset sharing score

Score breakdown

These five areas show where the dataset supports — or may limit — practical reuse.

Stewardship: 4
Harmonization: 8
Access: 4
Reuse readiness: 0
Engagement: 8

Topics

Homo sapiens Expression profiling by high throughput sequencing GEO gene expression

Dataset details

Repository: geo
Published: April 26, 2017
License: GEO-Open
DOI: geo/GSE98212

Scored with release 0.9.0

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

Start your CV How the NIH biosketch works